Logo for Reneo Pharmaceuticals Inc

Reneo Pharmaceuticals Investor Relations Material

Latest events

Logo for Reneo Pharmaceuticals

Q2 2024

13 Aug, 2024
Logo for Reneo Pharmaceuticals

Q1 2024

7 May, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies

Latest reports from Reneo Pharmaceuticals Inc

Access all reports
Reneo Pharmaceuticals Inc. is a clinical-stage pharmaceutical company focused on developing therapies for patients with rare genetic mitochondrial diseases. These diseases often involve the mitochondria's inability to efficiently produce energy for cells, impacting various bodily functions. The company is headquartered in San Diego, California, and its shares are listed on the Nasdaq.